{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,17]],"date-time":"2025-09-17T16:53:21Z","timestamp":1758128001350,"version":"3.41.0"},"reference-count":90,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["R01DA036583"],"award-info":[{"award-number":["R01DA036583"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Centre for Addition and Mental Health"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","cell.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","bmn.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Trends in Molecular Medicine"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1016\/j.molmed.2017.12.001","type":"journal-article","created":{"date-parts":[[2018,1,4]],"date-time":"2018-01-04T13:44:40Z","timestamp":1515073480000},"page":"187-196","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["Preparing the Way: Exploiting Genomic Medicine to Stop Smoking"],"prefix":"10.1016","volume":"24","author":[{"given":"Laura J.","family":"Bierut","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rachel F.","family":"Tyndale","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.molmed.2017.12.001_bib0005","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.15585\/mmwr.mm6544a2","article-title":"Current cigarette smoking among adults \u2013 United States, 2005\u20132015","volume":"65","author":"Centers for Disease Control","year":"2016","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"10.1016\/j.molmed.2017.12.001_bib0010","unstructured":"U.S. Department of Health and Human Services (2014) The Health Consequences of Smoking \u2013 50 Years of Progress: A Report of the Surgeon General. U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Offices on Smoking and Health"},{"year":"2007","series-title":"Ending the Tobacco Problem: A Blueprint for the Nation","author":"Institute of Medicine","key":"10.1016\/j.molmed.2017.12.001_bib0015"},{"key":"10.1016\/j.molmed.2017.12.001_bib0020","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.15585\/mmwr.mm6552a1","article-title":"Quitting smoking among adults \u2013 United States, 2000\u20132015","volume":"65","author":"Centers for Disease Control","year":"2017","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"10.1016\/j.molmed.2017.12.001_bib0025","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1111\/j.1360-0443.1989.tb03059.x","article-title":"Measuring the heaviness of smoking: using self-reported time to the first cigarette of the day and number of cigarettes smoked per day","volume":"84","author":"Heatherton","year":"1989","journal-title":"Br. J. Addict."},{"key":"10.1016\/j.molmed.2017.12.001_bib0030","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1136\/bmj.38142.554479.AE","article-title":"Mortality in relation to smoking: 50 years\u2019 observations on male British doctors","volume":"328","author":"Doll","year":"2004","journal-title":"BMJ"},{"key":"10.1016\/j.molmed.2017.12.001_bib0035","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/0306-4603(78)90024-2","article-title":"Measuring degree of physical dependence to tobacco smoking with reference to individualization of treatment","volume":"3","author":"Fagerstrom","year":"1978","journal-title":"Addict. Behav."},{"key":"10.1016\/j.molmed.2017.12.001_bib0040","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1056\/NEJM198307213090303","article-title":"Smokers of low-yield cigarettes do not consume less nicotine","volume":"309","author":"Benowitz","year":"1983","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.molmed.2017.12.001_bib0045","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1001\/jama.1986.03380020103032","article-title":"Reduced tar, nicotine, and carbon monoxide exposure while smoking ultralow- but not low-yield cigarettes","volume":"256","author":"Benowitz","year":"1986","journal-title":"JAMA"},{"key":"10.1016\/j.molmed.2017.12.001_bib0050","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1176\/appi.ajp.2012.11101545","article-title":"Interplay of genetic risk factors (CHRNA5-CHRNA3-CHRNB4) and cessation treatments in smoking cessation success","volume":"169","author":"Chen","year":"2012","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.molmed.2017.12.001_bib0055","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1111\/add.12353","article-title":"Pharmacotherapy effects on smoking cessation vary with nicotine metabolism gene (CYP2A6)","volume":"109","author":"Chen","year":"2014","journal-title":"Addiction"},{"key":"10.1016\/j.molmed.2017.12.001_bib0060","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.drugalcdep.2015.06.022","article-title":"Genetic variation (CHRNA5), medication (combination nicotine replacement therapy vs. varenicline), and smoking cessation","volume":"154","author":"Chen","year":"2015","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.molmed.2017.12.001_bib0065","doi-asserted-by":"crossref","first-page":"djv100","DOI":"10.1093\/jnci\/djv100","article-title":"CHRNA5 risk variant predicts delayed smoking cessation and earlier lung cancer diagnosis \u2013 a meta-analysis","volume":"107","author":"Chen","year":"2015","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.molmed.2017.12.001_bib0070","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1093\/hmg\/ddl441","article-title":"Novel genes identified in a high-density genome wide association study for nicotine dependence","volume":"16","author":"Bierut","year":"2007","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.molmed.2017.12.001_bib0075","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1093\/hmg\/ddl438","article-title":"Cholinergic nicotinic receptor genes implicated in a nicotine dependence association study targeting 348 candidate genes with 3713 SNPs","volume":"16","author":"Saccone","year":"2007","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.molmed.2017.12.001_bib0080","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1038\/ng.109","article-title":"Genome-wide association scan of tag SNPs identifies a susceptibility locus for lung cancer at 15q25.1","volume":"40","author":"Amos","year":"2008","journal-title":"Nat. Genet."},{"key":"10.1016\/j.molmed.2017.12.001_bib0085","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1038\/nature06885","article-title":"A susceptibility locus for lung cancer maps to nicotinic acetylcholine receptor subunit genes on 15q25","volume":"452","author":"Hung","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.molmed.2017.12.001_bib0090","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1000421","article-title":"A genome-wide association study in chronic obstructive pulmonary disease (COPD): identification of two major susceptibility loci","volume":"5","author":"Pillai","year":"2009","journal-title":"PLoS Genet."},{"key":"10.1016\/j.molmed.2017.12.001_bib0095","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1001053","article-title":"Multiple independent loci at chromosome 15q25.1 affect smoking quantity: a meta-analysis and comparison with lung cancer and COPD","volume":"6","author":"Saccone","year":"2010","journal-title":"PLoS Genet."},{"key":"10.1016\/j.molmed.2017.12.001_bib0100","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1038\/nature06846","article-title":"A variant associated with nicotine dependence, lung cancer and peripheral arterial disease","volume":"452","author":"Thorgeirsson","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.molmed.2017.12.001_bib0105","doi-asserted-by":"crossref","first-page":"4980","DOI":"10.1093\/hmg\/dds334","article-title":"Influence of common genetic variation on lung cancer risk: meta-analysis of 14900 cases and 29485 controls","volume":"21","author":"Timofeeva","year":"2012","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.molmed.2017.12.001_bib0110","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1038\/ng.571","article-title":"Genome-wide meta-analyses identify multiple loci associated with smoking behavior","volume":"42","author":"Tobacco and Genetics Consortium","year":"2010","journal-title":"Nat. Genet."},{"key":"10.1016\/j.molmed.2017.12.001_bib0115","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.ebiom.2016.08.012","article-title":"Genetic risk can be decreased: quitting smoking decreases and delays lung cancer for smokers with high and low CHRNA5 risk genotypes \u2013 a meta-analysis","volume":"11","author":"Chen","year":"2016","journal-title":"EBioMedicine"},{"key":"10.1016\/j.molmed.2017.12.001_bib0120","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms11174","article-title":"Variants near CHRNA3\/5 and APOE have age- and sex-related effects on human lifespan","volume":"7","author":"Joshi","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.molmed.2017.12.001_bib0125","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1093\/hmg\/ddt432","article-title":"Variants in two adjacent genes, EGLN2 and CYP2A6, influence smoking behavior related to disease risk via different mechanisms","volume":"23","author":"Bloom","year":"2014","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.molmed.2017.12.001_bib0130","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/sj.tpj.6500348","article-title":"CYP2A6 polymorphisms are associated with nicotine dependence and influence withdrawal symptoms in smoking cessation","volume":"6","author":"Kubota","year":"2006","journal-title":"Pharmacogenomics J."},{"key":"10.1016\/j.molmed.2017.12.001_bib0135","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.clpt.2004.10.011","article-title":"Implications of CYP2A6 genetic variation for smoking behaviors and nicotine dependence","volume":"77","author":"Malaiyandi","year":"2005","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.molmed.2017.12.001_bib0140","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1038\/ng.573","article-title":"Sequence variants at CHRNB3-CHRNA6 and CYP2A6 affect smoking behavior","volume":"42","author":"Thorgeirsson","year":"2010","journal-title":"Nat. Genet."},{"key":"10.1016\/j.molmed.2017.12.001_bib0145","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1093\/jnci\/djr237","article-title":"Relationship between CYP2A6 and CHRNA5-CHRNA3-CHRNB4 variation and smoking behaviors and lung cancer risk","volume":"103","author":"Wassenaar","year":"2011","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.molmed.2017.12.001_bib0150","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1097\/00007691-200202000-00026","article-title":"Genetic variation in CYP2A6-mediated nicotine metabolism alters smoking behavior","volume":"24","author":"Tyndale","year":"2002","journal-title":"Ther. Drug Monit."},{"key":"10.1016\/j.molmed.2017.12.001_bib0155","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1530\/EJE-11-0596","article-title":"Interaction between heavy smoking and CYP2A6 genotypes on type 2 diabetes and its possible pathways","volume":"165","author":"Liu","year":"2011","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.molmed.2017.12.001_bib0160","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/s12160-011-9318-5","article-title":"Relationship between amounts of daily cigarette consumption and abdominal obesity moderated by CYP2A6 genotypes in Chinese male current smokers","volume":"43","author":"Liu","year":"2012","journal-title":"Ann. Behav. Med."},{"key":"10.1016\/j.molmed.2017.12.001_bib0165","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/jhh.2011.111","article-title":"Association between daily cigarette consumption and hypertension moderated by CYP2A6 genotypes in Chinese male current smokers","volume":"27","author":"Liu","year":"2013","journal-title":"J. Hum. Hypertens."},{"key":"10.1016\/j.molmed.2017.12.001_bib0170","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1038\/sj.mp.4002154","article-title":"Alpha-5\/alpha-3 nicotinic receptor subunit alleles increase risk for heavy smoking","volume":"13","author":"Berrettini","year":"2008","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.molmed.2017.12.001_bib0175","doi-asserted-by":"crossref","DOI":"10.1038\/tp.2012.41","article-title":"Genome-wide meta-analyses of smoking behaviors in African Americans","volume":"2","author":"David","year":"2012","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.molmed.2017.12.001_bib0180","doi-asserted-by":"crossref","first-page":"6848","DOI":"10.1158\/0008-5472.CAN-09-0786","article-title":"The CHRNA5-CHRNA3-CHRNB4 nicotinic receptor subunit gene cluster affects risk for nicotine dependence in African\u2013Americans and in European\u2013Americans","volume":"69","author":"Saccone","year":"2009","journal-title":"Cancer Res."},{"key":"10.1016\/j.molmed.2017.12.001_bib0185","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1002\/gepi.21627","article-title":"Smoking and genetic risk variation across populations of European, Asian, and African American ancestry \u2013 a meta-analysis of chromosome 15q25","volume":"36","author":"Chen","year":"2012","journal-title":"Genet. Epidemiol."},{"key":"10.1016\/j.molmed.2017.12.001_bib0190","unstructured":"Purves, D. et al., eds (2011) Neuroscience, Sinauer Associates"},{"key":"10.1016\/j.molmed.2017.12.001_bib0195","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1176\/appi.ajp.2008.07111711","article-title":"Variants in nicotinic receptors and risk for nicotine dependence","volume":"165","author":"Bierut","year":"2008","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.molmed.2017.12.001_bib0200","doi-asserted-by":"crossref","first-page":"3125","DOI":"10.1093\/hmg\/ddp231","article-title":"Risk for nicotine dependence and lung cancer is conferred by mRNA expression levels and amino acid change in CHRNA5","volume":"18","author":"Wang","year":"2009","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.molmed.2017.12.001_bib0205","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1124\/mol.110.066357","article-title":"Acetylcholine receptor (AChR) alpha5 subunit variant associated with risk for nicotine dependence and lung cancer reduces (alpha4beta2)alpha5 AChR function","volume":"79","author":"Kuryatov","year":"2011","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.molmed.2017.12.001_bib0210","article-title":"Association of CYP2A6 activity with lung cancer incidence in smokers: the multiethnic cohort study","volume":"12","author":"Park","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.molmed.2017.12.001_bib0215","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1097\/00008571-200409000-00006","article-title":"Ethnic variation in CYP2A6 and association of genetically slow nicotine metabolism and smoking in adult Caucasians","volume":"14","author":"Schoedel","year":"2004","journal-title":"Pharmacogenetics"},{"key":"10.1016\/j.molmed.2017.12.001_bib0220","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1016\/S0090-9556(25)08453-3","article-title":"Role of human cytochrome P4502A6 in C-oxidation of nicotine","author":"Nakajima","year":"1996","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.molmed.2017.12.001_bib0225","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1016\/S0022-3565(25)12887-5","article-title":"Characterization of CYP2A6 involved in 3\u2032-hydroxylation of cotinine in human liver microsomes","volume":"277","author":"Nakajima","year":"1996","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.molmed.2017.12.001_bib0230","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1158\/1055-9965.EPI-14-0427","article-title":"Known and novel sources of variability in the nicotine metabolite ratio in a large sample of treatment-seeking smokers","volume":"23","author":"Chenoweth","year":"2014","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"key":"10.1016\/j.molmed.2017.12.001_bib0235","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.clpt.2004.02.011","article-title":"Nicotine metabolite ratio as an index of cytochrome P450 2A6 metabolic activity","volume":"76","author":"Dempsey","year":"2004","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.molmed.2017.12.001_bib0240","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/j.clpt.2006.09.007","article-title":"Nicotine intake and dose response when smoking reduced-nicotine content cigarettes","volume":"80","author":"Benowitz","year":"2006","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.molmed.2017.12.001_bib0245","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1046\/j.1469-1809.2000.6450383.x","article-title":"The use of long PCR to confirm three common alleles at the CYP2A6 locus and the relationship between genotype and smoking habit","volume":"64","author":"Gu","year":"2000","journal-title":"Ann. Hum. Genet."},{"key":"10.1016\/j.molmed.2017.12.001_bib0250","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1097\/FPC.0b013e32835f834d","article-title":"CYP2A6 slow nicotine metabolism is associated with increased quitting by adolescent smokers","volume":"23","author":"Chenoweth","year":"2013","journal-title":"Pharmacogenet. Genomics"},{"key":"10.1016\/j.molmed.2017.12.001_bib0255","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1038\/clpt.2008.57","article-title":"Toward personalized therapy for smoking cessation: a randomized placebo-controlled trial of bupropion","volume":"84","author":"Patterson","year":"2008","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.molmed.2017.12.001_bib0260","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1158\/1055-9965.EPI-08-0242","article-title":"Stability of the nicotine metabolite ratio in ad libitum and reducing smokers","volume":"17","author":"Mooney","year":"2008","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"key":"10.1016\/j.molmed.2017.12.001_bib0265","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1158\/1055-9965.EPI-14-1381","article-title":"Nicotine metabolite ratio (3-hydroxycotinine\/cotinine) in plasma and urine by different analytical methods and laboratories: implications for clinical implementation","volume":"24","author":"Tanner","year":"2015","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"issue":"Suppl 4","key":"10.1016\/j.molmed.2017.12.001_bib0270","first-page":"S555","article-title":"Time to first cigarette in the morning as an index of ability to quit smoking: implications for nicotine dependence","volume":"9","author":"Baker","year":"2007","journal-title":"Nicotine Tob. Res."},{"key":"10.1016\/j.molmed.2017.12.001_bib0275","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.2105\/AJPH.90.7.1122","article-title":"Predicting smoking cessation and major depression in nicotine-dependent smokers","volume":"90","author":"Breslau","year":"2000","journal-title":"Am. J. Public Health"},{"key":"10.1016\/j.molmed.2017.12.001_bib0280","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1111\/j.1360-0443.1991.tb01879.x","article-title":"The Fagerstrom Test for Nicotine Dependence: a revision of the Fagerstrom Tolerance Questionnaire","volume":"86","author":"Heatherton","year":"1991","journal-title":"Br. J. Addict."},{"key":"10.1016\/j.molmed.2017.12.001_bib0285","doi-asserted-by":"crossref","first-page":"2922","DOI":"10.1093\/hmg\/ddp216","article-title":"A common genetic variant in the 15q24 nicotinic acetylcholine receptor gene cluster (CHRNA5-CHRNA3-CHRNB4) is associated with a reduced ability of women to quit smoking in pregnancy","volume":"18","author":"Freathy","year":"2009","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.molmed.2017.12.001_bib0290","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1097\/FPC.0b013e32835cdabd","article-title":"Nicotinic acetylcholine receptor variation and response to smoking cessation therapies","volume":"23","author":"Bergen","year":"2013","journal-title":"Pharmacogenet. Genomics"},{"key":"10.1016\/j.molmed.2017.12.001_bib0295","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1002\/ajmg.b.31155","article-title":"Markers in the 15q24 nicotinic receptor subunit gene cluster (CHRNA5-A3-B4) predict severity of nicotine addiction and response to smoking cessation therapy","volume":"156B","author":"Sarginson","year":"2011","journal-title":"Am. J. Med. Genet. B Neuropsychiatr. Genet."},{"key":"10.1016\/j.molmed.2017.12.001_bib0300","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1093\/ntr\/ntu273","article-title":"Response to transdermal selegiline smoking cessation therapy and markers in the 15q24 chromosomal region","volume":"17","author":"Sarginson","year":"2015","journal-title":"Nicotine Tob. Res."},{"key":"10.1016\/j.molmed.2017.12.001_bib0305","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1038\/clpt.2014.88","article-title":"Association of CHRNA5-A3-B4 SNP rs2036527 with smoking cessation therapy response in African\u2013American smokers","volume":"96","author":"Zhu","year":"2014","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.molmed.2017.12.001_bib0310","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.tips.2016.09.006","article-title":"Pharmacogenetic optimization of smoking cessation treatment","volume":"38","author":"Chenoweth","year":"2017","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.molmed.2017.12.001_bib0315","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0128109","article-title":"Lack of associations of CHRNA5-A3-B4 genetic variants with smoking cessation treatment outcomes in Caucasian smokers despite associations with baseline smoking","volume":"10","author":"Tyndale","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.molmed.2017.12.001_bib0320","first-page":"CD011823","article-title":"Pharmacotherapy for smoking cessation: effects by subgroup defined by genetically informed biomarkers","volume":"9","author":"Schuit","year":"2017","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.molmed.2017.12.001_bib0325","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.pbb.2008.10.016","article-title":"Nicotine metabolic rate predicts successful smoking cessation with transdermal nicotine: a validation study","volume":"92","author":"Schnoll","year":"2009","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.molmed.2017.12.001_bib0330","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.clpt.2006.02.006","article-title":"Nicotine metabolite ratio predicts efficacy of transdermal nicotine for smoking cessation","volume":"79","author":"Lerman","year":"2006","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.molmed.2017.12.001_bib0335","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S2213-2600(14)70294-2","article-title":"Use of the nicotine metabolite ratio as a genetically informed biomarker of response to nicotine patch or varenicline for smoking cessation: a randomised, double-blind placebo-controlled trial","volume":"3","author":"Lerman","year":"2015","journal-title":"Lancet Respir. Med."},{"key":"10.1016\/j.molmed.2017.12.001_bib0340","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1002\/gepi.20516","article-title":"Quality control and quality assurance in genotypic data for genome-wide association studies","volume":"34","author":"Laurie","year":"2010","journal-title":"Genet. Epidemiol."},{"key":"10.1016\/j.molmed.2017.12.001_bib0345","article-title":"Genome-wide association study of a nicotine metabolism biomarker in African American smokers: impact of chromosome 19 genetic influences","author":"Chenoweth","year":"2017","journal-title":"Addiction"},{"key":"10.1016\/j.molmed.2017.12.001_bib0350","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1005498","article-title":"A genome-wide association study of a biomarker of nicotine metabolism","volume":"11","author":"Loukola","year":"2015","journal-title":"PLoS Genet."},{"key":"10.1016\/j.molmed.2017.12.001_bib0355","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1097\/FPC.0000000000000317","article-title":"Novel CYP2A6 diplotypes identified through next-generation sequencing are associated with in-vitro and in-vivo nicotine metabolism","volume":"28","author":"Tanner","year":"2017","journal-title":"Pharmacogenet. Genomics"},{"key":"10.1016\/j.molmed.2017.12.001_bib0360","doi-asserted-by":"crossref","first-page":"147","DOI":"10.2217\/pgs.15.156","article-title":"CYP2A6 genotyping methods and strategies using real-time and end point PCR platforms","volume":"17","author":"Wassenaar","year":"2016","journal-title":"Pharmacogenomics"},{"key":"10.1016\/j.molmed.2017.12.001_bib0365","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1093\/ntr\/ntv031","article-title":"Test-retest reliability and stability of the nicotine metabolite ratio among treatment-seeking smokers","volume":"17","author":"Hamilton","year":"2015","journal-title":"Nicotine Tob. Res."},{"key":"10.1016\/j.molmed.2017.12.001_bib0370","doi-asserted-by":"crossref","first-page":"464","DOI":"10.3109\/15412555.2015.1049260","article-title":"CHRNA5\/CHRNA3 locus associates with increased mortality among smokers","volume":"13","author":"Kupiainen","year":"2016","journal-title":"COPD"},{"year":"2017","series-title":"An Evidence Framework for Genetic Testing","author":"National Academies of Sciences, Engineering, and Medicine","key":"10.1016\/j.molmed.2017.12.001_bib0375"},{"key":"10.1016\/j.molmed.2017.12.001_bib0380","doi-asserted-by":"crossref","first-page":"49","DOI":"10.2147\/POR.S137701","article-title":"The value of pragmatic and observational studies in health care and public health","volume":"8","author":"Barnish","year":"2017","journal-title":"Pragmat. Obs. Res."},{"key":"10.1016\/j.molmed.2017.12.001_bib0385","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1186\/s13063-017-2240-9","article-title":"A framework for the design, conduct and interpretation of randomised controlled trials in the presence of treatment changes","volume":"18","author":"Dodd","year":"2017","journal-title":"Trials"},{"key":"10.1016\/j.molmed.2017.12.001_bib0390","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1513\/AnnalsATS.201401-010OC","article-title":"Beyond cigarettes per day. A genome-wide association study of the biomarker carbon monoxide","volume":"11","author":"Bloom","year":"2014","journal-title":"Ann. Am. Thorac. Soc."},{"key":"10.1016\/j.molmed.2017.12.001_bib0395","doi-asserted-by":"crossref","first-page":"9137","DOI":"10.1158\/0008-5472.CAN-08-2271","article-title":"Smokers with the CHRNA lung cancer-associated variants are exposed to higher levels of nicotine equivalents and a carcinogenic tobacco-specific nitrosamine","volume":"68","author":"Le Marchand","year":"2008","journal-title":"Cancer Res."},{"key":"10.1016\/j.molmed.2017.12.001_bib0400","doi-asserted-by":"crossref","DOI":"10.1093\/ntr\/ntx097","article-title":"Leveraging genomic data in smoking cessation trials in the era of precision medicine: why and how","author":"Chen","year":"2018","journal-title":"Nicotine Tob. Res."},{"key":"10.1016\/j.molmed.2017.12.001_bib0405","article-title":"2017 Pathways to precision medicine in smoking cessation treatments","author":"Chen","year":"2017","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.molmed.2017.12.001_bib0410","doi-asserted-by":"crossref","first-page":"210","DOI":"10.3389\/fgene.2012.00210","article-title":"Clinical applications of gene-based risk prediction for lung cancer and the central role of chronic obstructive pulmonary disease","volume":"3","author":"Young","year":"2012","journal-title":"Front. Genet."},{"key":"10.1016\/j.molmed.2017.12.001_bib0415","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1093\/ntr\/ntu155","article-title":"A preliminary exploration of college smokers\u2019 reactions to nicotine dependence genetic susceptibility feedback","volume":"17","author":"Lipkus","year":"2015","journal-title":"Nicotine Tob. Res."},{"key":"10.1016\/j.molmed.2017.12.001_bib0420","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1093\/ntr\/ntw168","article-title":"Implications of personal genomic testing for health behaviors: the case of smoking","volume":"18","author":"Olfson","year":"2016","journal-title":"Nicotine Tob. Res."},{"key":"10.1016\/j.molmed.2017.12.001_bib0425","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1038\/gim.2014.110","article-title":"Return of individual genetic results in a high-risk sample: enthusiasm and positive behavioral change","volume":"17","author":"Hartz","year":"2015","journal-title":"Genet. Med."},{"key":"10.1016\/j.molmed.2017.12.001_bib0430","doi-asserted-by":"crossref","first-page":"i1102","DOI":"10.1136\/bmj.i1102","article-title":"The impact of communicating genetic risks of disease on risk-reducing health behaviour: systematic review with meta-analysis","volume":"352","author":"Hollands","year":"2016","journal-title":"BMJ"},{"key":"10.1016\/j.molmed.2017.12.001_bib0435","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1186\/1471-2458-10-680","article-title":"Trial protocol: using genotype to tailor prescribing of nicotine replacement therapy: a randomised controlled trial assessing impact of communication upon adherence","volume":"10","author":"Marteau","year":"2010","journal-title":"BMC Public Health"},{"key":"10.1016\/j.molmed.2017.12.001_bib0440","first-page":"CD007275","article-title":"Effects of communicating DNA-based disease risk estimates on risk-reducing behaviours","author":"Marteau","year":"2010","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.molmed.2017.12.001_bib0445","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1038\/ng.572","article-title":"Meta-analysis and imputation refines the association of 15q25 with smoking quantity","volume":"42","author":"Liu","year":"2010","journal-title":"Nat. Genet."},{"key":"10.1016\/j.molmed.2017.12.001_bib0450","unstructured":"Jiang, Y. (2017) GWAS meta-analysis identifies > 200 novel loci for smoking and drinking addiction. American Society of Human Genetics Annual Meeting, Orlando, FL"}],"container-title":["Trends in Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471491417302137?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471491417302137?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,29]],"date-time":"2025-06-29T10:49:37Z","timestamp":1751194177000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1471491417302137"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2]]},"references-count":90,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,2]]}},"alternative-id":["S1471491417302137"],"URL":"https:\/\/doi.org\/10.1016\/j.molmed.2017.12.001","relation":{},"ISSN":["1471-4914"],"issn-type":[{"type":"print","value":"1471-4914"}],"subject":[],"published":{"date-parts":[[2018,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Preparing the Way: Exploiting Genomic Medicine to Stop Smoking","name":"articletitle","label":"Article Title"},{"value":"Trends in Molecular Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.molmed.2017.12.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}